Article

A retrospective study of tislelizumab combined with chemotherapy for downstaging and conversion therapy in patients with locally advanced lung cancer

2026-04-10

Abstract excerpt

<title>Abstract</title> <p> <bold>Objective:</bold> This study aimed to evaluate the efficacy and safety of tislelizumab combined with chemotherapy in patients with locally advanced lung cancer through the retrospective collection of real-world data. <bold>Methods:</bold> This study was a single-arm, multicenter, retrospective, real-world study. The study mainly includes patients with locally advanced lung ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d6f8408-1d9d-57a7-a0a8-394c78598e2e
DOI: 10.21203/rs.3.rs-8839391/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A retrospective study of tislelizumab combined with chemotherapy for downstaging and conversion therapy in patients with locally advanced lung cancerDOI 10.21203/rs.3.rs-8839391/v1Read

[Annual therapeutic advances in advanced non-small cell lung cancer in 2024].Semantic proximity Read

Effects of anlotinib combined with second-line chemotherapy on the levels of immune cells and inflammatory factors and the curative effects in patients with advanced non-small cell lung cancerSemantic proximity Read

Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancerSemantic proximity Read

Real-world Data Analysis of Immunotherapy in Advanced Lung CancerSemantic proximity Read

A systematic review and meta-analysis on effectiveness and safety of traditional Chinese medicine combined with EGFR-TKIs in treating advanced non-small cell lung cancerSemantic proximity Read

Comparative Safety of Immune Checkpoint Inhibitors and Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisSemantic proximity Read

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.Semantic proximity Read

Efficacy and safety of different PD-1 inhibitors as first-line treatment for advanced or metastatic squamous non-small cell lung cancer: A retrospective real-world studySemantic proximity Read

Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring STK11 Genetic Aberration: A Protocol of Phase II Study.Semantic proximity Read

A Single Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally-Advanced Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read

Oncological therapy in stage IV lung cancer patients at the end-of-life – A retrospective single-center cohort analysis in the era of tyrosine kinase inhibition and immunotherapySemantic proximity Read

125I brachytherapy as consolidative local therapy for patients with synchonous oligometastatic non-small cell lung cancer without progression after first-line chemotherapy plus PD-1 inhibitors treatment：A retrospective observational studySemantic proximity Read